BALB/c Nude

1. Endothelial SMAD1-MCAM axis facilitates sunitinib resistance and progression of clear cell renal cell carcinoma via LAMB1-ITGB1 signaling
发表年份：2026 来源杂志：DRUG RESISTANCE UPDATES

2. SMAD4 Palmitoylation Drives a Metabolic-Transcriptional Circuit to Promote Tumorigenesis and Confers Radiosensitivity in Pancreatic Cancer
发表年份：2026 来源杂志：Advanced Science

3. Targeting the FOSL1/IKKα positive feedback loop attenuates glioblastoma malignancy via suppression of NF-κB signaling
发表年份：2026 来源杂志：Theranostics

4. Loss of TFAM Accelerates Pentose Phosphate Pathway by Unleashing G6PD Oligomerization to Drive Hepatocarcinogenesis
发表年份：2026 来源杂志：CANCER LETTERS

5. Melanoma exosomal miR-708-5p promotes macrophage M2 polarization and cancer metastasis
发表年份：2026 来源杂志：Cell Death & Disease

6. GSH-Activated Cu-TCPP(Zn)/Ti3C2Tx Nanozymes for Fluorescence Imaging-Guided Synergistic Photodynamic/Chemodynamic Therapy of Oral Squamous Cell Carcinoma
发表年份：2026 来源杂志：ACS Applied Materials & Interfaces

7. Modulating tumor-associated macrophages through APP-CD74 blockade with IL4R-exosomes synergizes with PD-1 inhibition in gastric cancer
发表年份：2026 来源杂志：npj Precision Oncology

8. ADCY7 dictates N-cadherin stability to inhibit HCC metastasis
发表年份：2026 来源杂志：JHEP Reports

9. 89Zr/177Lu-Labeled Radioimmunoconjugates Targeting SORT1 for Cancer Theranostics
发表年份：2026 来源杂志：JOURNAL OF MEDICINAL CHEMISTRY

10. MD2 suppresses anaplastic thyroid Cancer progression by reprogramming macrophages via USP15-mediated FHL1 Deubiquitination
发表年份：2026 来源杂志：INTERNATIONAL IMMUNOPHARMACOLOGY

11. KCTD15 Enhances Stem Cell‐Like Properties and Promotes Triple‐Negative Breast Cancer Progression Through KLF4/β‐Catenin Signaling
发表年份：2026 来源杂志：FASEB JOURNAL

12. FOXA2/ALDOB axis modulation of fatty acid beta-oxidation influences irinotecan resistance in colorectal cancer
发表年份：2026 来源杂志：BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

13. Calycosin exerts anti-glioblastoma effects by inhibiting GPX-4 to promote oxidative stress
发表年份：2026 来源杂志：BRAIN RESEARCH BULLETIN

14. Multi-omics analysis identifies BUB1B as a cell cycle–related driver of bladder cancer progression
发表年份：2026 来源杂志：World Journal of Surgical Oncology

15. Loss of GPR133 Promotes Enzalutamide Resistance in Prostate Cancer by Upregulating HSD3B1 and Intratumoral Androgen Synthesis
发表年份：2026 来源杂志：PROSTATE

16. CEACAM6 silencing suppresses tumour growth and sensitises cholangiocarcinoma to cisplatin
发表年份：2026 来源杂志：Clinical and Translational Discovery

17. BAG2 releases SAMD4B upon sensing of arginine deficiency to promote tumor cell survival
发表年份：2025 来源杂志：MOLECULAR CELL

18. Malignant Hepatoblast-Like Cells Sustain Stemness via IGF2-Dependent Cholesterol Accumulation in Hepatoblastoma
发表年份：2025 来源杂志：Advanced Science

19. A Self-Assembling LYTAC Mediates CTGF Degradation and Remodels Inflammatory Tumor Microenvironment for Triple-Negative Breast Cancer Therapy
发表年份：2025 来源杂志：Advanced Science

20. NPR1 Promotes Lipid Droplet Lipolysis to Enhance Mitochondrial Oxidative Phosphorylation and Fuel Gastric Cancer Metastasis
发表年份：2025 来源杂志：Advanced Science

21. Targeting Hyperglycemic Bone Pre-Metastatic Niche for Breast Cancer Bone Metastasis Therapy
发表年份：2025 来源杂志：Advanced Science

22. FAM50A drives breast cancer brain metastasis through interaction with C9ORF78 to enhance ʟ-asparagine production
发表年份：2025 来源杂志：Science Advances

23. Targeting the ac4C ‘Writer’ NAT10 enhances pancreatic cancer immunotherapy via dual modulation of CD8+ T cells and tumor cells
发表年份：2025 来源杂志：Cell Death & Disease

24. Targeting SH3GL1 for Prognosis and Immune Response in Breast Cancer
发表年份：2025 来源杂志：Journal of Pharmaceutical Analysis

25. Sino-C, a novel sinomenine derivative, induces cell death by disrupting cholesterol homeostasis in colorectal cancer cells
发表年份：2025 来源杂志：ACTA PHARMACOLOGICA SINICA

26. Yuanhuacine suppresses head and neck cancer growth by promoting ASCT2 degradation and inhibiting glutamine uptake
发表年份：2025 来源杂志：ACTA PHARMACOLOGICA SINICA

27. Phosphorylation enhanced OTUD3 deubiquitination ARID3A promotes the progress of cholangiocarcinoma
发表年份：2025 来源杂志：ONCOGENE

28. RSK1 reprograms the ubiquitin pathway to promote immune suppression
发表年份：2025 来源杂志：Cell Reports

29. Targeting CDK9 With Harmine Induces Homologous Recombination Deficiency and Synergizes With PARP Inhibitors in Ovarian Cancer
发表年份：2025 来源杂志：PHYTOTHERAPY RESEARCH

30. Synergistic inhibition of TNBC by USP33 and TAP63 through autophagy and ferroptosis activation
发表年份：2025 来源杂志：CELLULAR AND MOLECULAR LIFE SCIENCES

31. Two chemotherapeutic agents expand stem-like CD62L+CD8+ T cells in antitumor immune responses
发表年份：2025 来源杂志：Frontiers in Immunology

32. Identification of CTSC-driven progression in ESCC by single-cell sequencing and experimental validation
发表年份：2025 来源杂志：Frontiers in Immunology

33. Magnetically actuated superparamagnetic liposomes for accurate photothermal therapy and in situ antitumor immunoactivation
发表年份：2025 来源杂志：Biomaterials Science

34. NR1I3 inhibits colorectal cancer growth by enhancing PCK1-mediated gluconeogenesis
发表年份：2025 来源杂志：CHEMICO-BIOLOGICAL INTERACTIONS

35. Inhibition of Dormant Lung Cancer Cell Reactivation by Punica Granatum Peel and Dioscorea Nipponica: Involving MYC, SKP2 and p27
发表年份：2025 来源杂志：Drug Design Development and Therapy

36. Kinsenoside Suppresses DGAT1-Mediated Lipid Droplet Formation to Trigger Ferroptosis in Triple-Negative Breast Cancer
发表年份：2025 来源杂志：INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

37. Targeting the cuproptosis‑associated gene COL22A1 in glioblastoma using EMD‑1204831 and kaempferol
发表年份：2025 来源杂志：INTERNATIONAL JOURNAL OF ONCOLOGY

38. Exosome-derived SLC12A2-DT promotes macrophage M2 polarization-mediated hepatocellular carcinoma progression
发表年份：2025 来源杂志：INTERNATIONAL IMMUNOPHARMACOLOGY

39. Nanobody-Based PET Imaging of CD47 Expression in Thyroid Carcinoma
发表年份：2025 来源杂志：MOLECULAR PHARMACEUTICS

40. Mycobacterial antigen Ag85B restrains Hodgkin lymphoma tumor growth by inhibiting autophagy
发表年份：2025 来源杂志：ONCOLOGY RESEARCH

41. ADAMDEC1 promotes the malignant progression of cholangiocarcinoma by regulating NF-κB signaling pathway
发表年份：2025 来源杂志：Scientific Reports

42. The lysosomal cysteine protease cathepsin L promotes stemness and multidrug resistance of non-small cell lung cancer by targeting HGF activator
发表年份：2025 来源杂志：MOLECULAR AND CELLULAR BIOCHEMISTRY

43. APOBEC3B-driven mutations negatively regulated by P53 promote tumor progression and immunosuppressive microenvironment in prostate cancer
发表年份：2025 来源杂志：MOLECULAR AND CELLULAR BIOCHEMISTRY

44. Unraveling the secrets of UBE2S in endometrial cancer: Potential targets for diagnosis, prognostic assessment, and ferroptosis therapy
发表年份：2025 来源杂志：CELLULAR SIGNALLING

45. BRAP Promotes the Tumorigenesis of Hepatocellular Carcinoma by Corrupting Cancer Cell Cycle Regulation and Enhancing Immune Evasion
发表年份：2025 来源杂志：Journal of Hepatocellular Carcinoma

46. VDAC1 as prognostic marker and therapeutic target in lung adenocarcinoma: a study integrating bioinformatics and experimental validation
发表年份：2025 来源杂志：Discover Oncology

47. Exploring the Anticancer Effects of Xianliu Jieduan Fang on Colitis-Associated Colorectal Cancer Through Network Pharmacology and Experimental Validation
发表年份：2025 来源杂志：BIOMEDICAL CHROMATOGRAPHY

48. Propofol Inhibits Lung Cancer Glycolysis by Influencing the Deubiquitination Modification of TPI1 Regulated by USP5
发表年份：2025 来源杂志：BIOCHEMICAL GENETICS

49. BCAA-producing Clostridium symbiosum promotes colorectal tumorigenesis through the modulation of host cholesterol metabolism
发表年份：2024 来源杂志：Cell Host & Microbe

50. The adhesin RadD enhances Fusobacterium nucleatum tumour colonization and colorectal carcinogenesis
发表年份：2024 来源杂志：Nature Microbiology

51. Acetate utilization promotes hormone therapy resistance in prostate cancer through neuroendocrine differentiation
发表年份：2024 来源杂志：DRUG RESISTANCE UPDATES

52. Effect of Bioactive Black Phosphorus Nanomaterials on Cancer-Associated Fibroblast Heterogeneity in Pancreatic Cancer
发表年份：2024 来源杂志：ACS Nano

53. Human papillomavirus-encoded circular RNA circE7 promotes immune evasion in head and neck squamous cell carcinoma
发表年份：2024 来源杂志：Nature Communications

54. CRL3Keap1 E3 ligase facilitates ubiquitin-mediated degradation of oncogenic SRX to suppress colorectal cancer progression
发表年份：2024 来源杂志：Nature Communications

55. Dual Inhibition of CDK4/6 and CDK7 Suppresses Triple-Negative Breast Cancer Progression via Epigenetic Modulation of SREBP1-Regulated Cholesterol Metabolism
发表年份：2024 来源杂志：Advanced Science

56. Aspirin-Mediated Acetylation of SIRT1 Maintains Intestinal Immune Homeostasis
发表年份：2024 来源杂志：Advanced Science

57. A STT3A-dependent PD-L1 glycosylation modification mediated by GMPS drives tumor immune evasion in hepatocellular carcinoma
发表年份：2024 来源杂志：CELL DEATH AND DIFFERENTIATION

58. Cuproptosis and Serine Metabolism Blockade Triggered by Copper-Based Prussian Blue Nanomedicine for Enhanced Tumor Therapy
发表年份：2024 来源杂志：Small

59. LncRNA SNHG1 facilitates colorectal cancer cells metastasis by recruiting HNRNPD protein to stabilize SERPINA3 mRNA
发表年份：2024 来源杂志：CANCER LETTERS

60. Kappa opioid receptor internalisation-induced p38 nuclear translocation suppresses glioma progression
发表年份：2024 来源杂志：BRITISH JOURNAL OF ANAESTHESIA

61. Machine learning-aided discovery of T790M-mutant EGFR inhibitor CDDO-Me effectively suppresses non-small cell lung cancer growth
发表年份：2024 来源杂志：Cell Communication and Signaling

62. The interaction between UBR7 and PRMT5 drives PDAC resistance to gemcitabine by regulating glycolysis and immune microenvironment
发表年份：2024 来源杂志：Cell Death & Disease

63. Selective PI3Kδ inhibitor TYM-3-98 suppresses AKT/mTOR/SREBP1-mediated lipogenesis and promotes ferroptosis in KRAS-mutant colorectal cancer
发表年份：2024 来源杂志：Cell Death & Disease

64. Chaperonin-containing TCP1 subunit 6A inhibition via TRIM21-mediated K48-linked ubiquitination suppresses triple-negative breast cancer progression through the AKT signalling pathway
发表年份：2024 来源杂志：Clinical and Translational Medicine

65. SSRI antidepressant citalopram reverses the Warburg effect to inhibit hepatocellular carcinoma by directly targeting GLUT1
发表年份：2024 来源杂志：Cell Reports

66. Engineered Bacteria for Visualization and Localization of Gastrointestinal Bleeding: A Promising Application
发表年份：2024 来源杂志：ANALYTICAL CHEMISTRY

67. Effect of the mRNA decapping enzyme scavenger (DCPS) inhibitor RG3039 on glioblastoma
发表年份：2024 来源杂志：Journal of Translational Medicine

68. NID1 promotes laryngeal cancer stemness via activating WNT pathway
发表年份：2024 来源杂志：Biology Direct

69. Single-cell analysis defines LGALS1+ fibroblasts that promote proliferation and migration of intrahepatic cholangiocarcinoma
发表年份：2024 来源杂志：Journal of Molecular Cell Biology

70. Immune alterations and overexpression of CTCF in endometrial carcinoma: insights from molecular subtyping
发表年份：2024 来源杂志：Cancer Cell International

71. Imperatorin Suppresses Aberrant Hedgehog Pathway and Overcomes Smoothened Antagonist Resistance via STAT3 Inhibition
发表年份：2024 来源杂志：Drug Design Development and Therapy

72. Hypoxia-Derived Exosomes Promote Lung Adenocarcinoma by Regulating HS3ST1-GPC4-Mediated Glycolysis
发表年份：2024 来源杂志：Cancers

73. CHES1 modulated tumorigenesis and senescence of pancreas cancer cells through repressing AKR1B10
发表年份：2024 来源杂志：BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

74. FOXF1 promotes ovarian cancer metastasis by facilitating HMGA2-mediated USP30-dependent S100A6 deubiquitination
发表年份：2024 来源杂志：BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

75. THBS2 promotes gastric cancer progression and stemness via the Notch signaling pathway
发表年份：2024 来源杂志：American Journal of Cancer Research

76. Quercetin Attenuates Cancer-Associated Fibroblast Activation via Tumor-Stromal Interactions and Demonstrates Its Clinical Value in Pancreatic Cancer
发表年份：2024 来源杂志：JOURNAL OF FOOD BIOCHEMISTRY

77. TREM1 promotes cancer associated malignant phenotype through activated MAPK signaling pathway and predicts poor prognosis in gastric cancer
发表年份：2024 来源杂志：Heliyon

78. Toll-like receptor 6 inhibits colorectal cancer progression by suppressing NF-κB signaling
发表年份：2024 来源杂志：Heliyon

79. RBM5 suppresses proliferation, metastasis and glycolysis of colorectal cancer cells via stabilizing phosphatase and tensin homolog mRNA
发表年份：2024 来源杂志：World Journal of Gastrointestinal Oncology

80. Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma
发表年份：2023 来源杂志：Molecular Cancer

81. Targeted therapy of central nervous system acute lymphoblastic leukemia with an integrin α6-targeted self-assembling proapoptotic nanopeptide
发表年份：2023 来源杂志：Engineering

82. Epitranscriptic regulation of HRAS by N6-methyladenosine drives tumor progression
发表年份：2023 来源杂志：PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

83. Kaempferol inhibits non-homologous end joining repair via regulating Ku80 stability in glioma cancer
发表年份：2023 来源杂志：PHYTOMEDICINE

84. TGF-β-p-STAT1-LAIR2 axis has a “self-rescue” role for exhausted CD8+ T cells in hepatocellular carcinoma
发表年份：2023 来源杂志：CELLULAR ONCOLOGY

85. Crizotinib‐based proteolysis targeting chimera suppresses gastric cancer by promoting MET degradation
发表年份：2023 来源杂志：CANCER SCIENCE

86. Programmed death ligand 1 regulates epithelial–mesenchymal transition and cancer stem cell phenotypes in hepatocellular carcinoma through the serum and glucocorticoid kinase 2/β‐catenin signaling pathway
发表年份：2023 来源杂志：CANCER SCIENCE

87. CCL17 acts as an antitumor chemokine in micromilieu‐driven immune skewing
发表年份：2023 来源杂志：INTERNATIONAL IMMUNOPHARMACOLOGY

88. STL127705 synergize with olaparib in castration-resistant prostate cancer by inhibiting homologous recombination and non-homologous end-joining repair
发表年份：2023 来源杂志：American Journal of Cancer Research

89. Tumor-associated macrophages-derived exo-let-7a promotes osteosarcoma metastasis via targeting C15orf41 in osteosarcoma
发表年份：2023 来源杂志：ENVIRONMENTAL TOXICOLOGY

90. Up-regulation of PUM1 by miR-218-5p promotes colorectal tumor-initiating cell properties and tumorigenesis by regulating the PI3K/AKT axis
发表年份：2023 来源杂志：Journal of Gastrointestinal Oncology

91. Small extracellular vesicle-mediated miR-320e transmission promotes osteogenesis in OPLL by targeting TAK1
发表年份：2022 来源杂志：Nature Communications

92. A multimodal Metal-Organic framework based on unsaturated metal site for enhancing antitumor cytotoxicity through Chemo-Photodynamic therapy
发表年份：2022 来源杂志：JOURNAL OF COLLOID AND INTERFACE SCIENCE

93. MIR210HG promotes breast cancer progression by IGF2BP1 mediated m6A modification
发表年份：2022 来源杂志：Cell and Bioscience

94. Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer
发表年份：2022 来源杂志：JCI Insight

95. Metformin abrogates Fusobacterium nucleatum-induced chemoresistance in colorectal cancer by inhibiting miR-361-5p/sonic hedgehog signaling-regulated stemness
发表年份：2022 来源杂志：BRITISH JOURNAL OF CANCER

96. HMGCL-induced β-hydroxybutyrate production attenuates hepatocellular carcinoma via DPP4-mediated ferroptosis susceptibility
发表年份：2022 来源杂志：Hepatology International

97. ABI2-mediated MEOX2/KLF4-NANOG axis promotes liver cancer stem cell and drives tumour recurrence
发表年份：2022 来源杂志：LIVER INTERNATIONAL

98. Photonic hyperthermia of malignant peripheral nerve sheath tumors at the third near-infrared biowindow
发表年份：2022 来源杂志：eLife

99. Oncogenic lncRNA ZNFX1 antisense RNA 1 promotes osteosarcoma cells proliferation and metastasis by stabilizing serine and arginine‑rich splicing factor 3
发表年份：2022 来源杂志：Bioengineered

100. Bcl-2 interacting protein 3 (BNIP3) promotes tumor growth in breast cancer under hypoxic conditions through an autophagy-dependent pathway
发表年份：2022 来源杂志：Bioengineered

101. Fusobacterium nucleatum stimulates cell proliferation and promotes PD-L1 expression via IFIT1-related signal in colorectal cancer
发表年份：2022 来源杂志：NEOPLASIA

102. Pigment epithelium-derived factor, an anti-VEGF factor, delays ovarian cancer progression by alleviating polarization of tumor-associated macrophages
发表年份：2022 来源杂志：CANCER GENE THERAPY

103. Flower-like Composite Material Delivery of Co-Packaged Lenvatinib and Bufalin Prevents the Migration and Invasion of Cholangiocarcinoma
发表年份：2022 来源杂志：Nanomaterials

104. Knockdown of membrane-bound complement regulatory proteins suppresses colon cancer growth in mice through inducing tumor cell apoptosis
发表年份：2022 来源杂志：INTERNATIONAL IMMUNOPHARMACOLOGY

105. Novel long non-coding RNA CYB561-5 promotes aerobic glycolysis and tumorigenesis by interacting with basigin in non-small cell lung cancer
发表年份：2022 来源杂志：JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

106. Hsa_circ_0074298 promotes pancreatic cancer progression and resistance to gemcitabine by sponging miR-519 to target SMOC
发表年份：2022 来源杂志：Journal of Cancer

107. Mesoporous Silica Nanoparticles Loaded with Resveratrol Are Used for Targeted Breast Cancer Therapy
发表年份：2022 来源杂志：Journal of Oncology

108. Long non-coding RNA TDRG1 aggravates colorectal cancer stemness by binding with miR-873-5p to upregulate PRKAR2
发表年份：2022 来源杂志：ENVIRONMENTAL TOXICOLOGY

109. CtBP proteins transactivate matrix metalloproteinases and proinflammatory cytokines to mediate the pathogenesis of abdominal aortic aneurysm
发表年份：2022 来源杂志：EXPERIMENTAL CELL RESEARCH

110. Sasanquasaponin inhibited epithelial to mesenchymal transition in prostate cancer by regulating the PI3K/Akt/mTOR and Smad pathways
发表年份：2022 来源杂志：PHARMACEUTICAL BIOLOGY

111. Long Noncoding RNA AATBC Promotes the Proliferation and Migration of Prostate Cancer Cell Through miR-1245b-5p/CASK Axis
发表年份：2022 来源杂志：Cancer Management and Research

112. Sanguinarine Represses the Growth and Metastasis of Non-small Cell Lung Cancer by Facilitating Ferroptosis
发表年份：2022 来源杂志：CURRENT PHARMACEUTICAL DESIGN

113. Tripartite Motif Containing 26 is a Positive Predictor for Endometrial Carcinoma Patients and Regulates Cell Survival in Endometrial Carcinoma
发表年份：2022 来源杂志：HORMONE AND METABOLIC RESEARCH

114. Long-Noncoding RNA ANCR Activates the Hedgehog Signaling Pathway to Promote Basal Cell Carcinoma Progression by Binding to PTCH
发表年份：2022 来源杂志：Clinical Cosmetic and Investigational Dermatology

115. RNA-binding protein RBM24 represses colorectal tumourigenesis by stabilising PTEN mRNA
发表年份：2021 来源杂志：Clinical and Translational Medicine

116. Nitric Oxide Prodrug Delivery and Release Monitoring Based on a Galactose-Modified Multifunctional Nanoprobe
发表年份：2021 来源杂志：ANALYTICAL CHEMISTRY

117. Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer
发表年份：2021 来源杂志：International Journal of Nanomedicine

118. Enzalutamide-Induced Upregulation of PCAT6 Promotes Prostate Cancer Neuroendocrine Differentiation by Regulating miR-326/HNRNPA2B1 Axis
发表年份：2021 来源杂志：Frontiers in Oncology

119. LncRNA-SNHG1 promotes macrophage M2-like polarization and contributes to breast cancer growth and metastasis
发表年份：2021 来源杂志：Aging-US

120. Downregulated F-Box/LRR-Repeat Protein 7 Facilitates Pancreatic Cancer Metastasis by Regulating Snail1 for Proteasomal Degradation
发表年份：2021 来源杂志：Frontiers in Genetics

121. Fat1 suppresses the tumor-initiating ability of nonsmall cell lung cancer cells by promoting Yes-associated protein 1 nuclear-cytoplasmic translocation
发表年份：2021 来源杂志：ENVIRONMENTAL TOXICOLOGY

122. RNF168 suppresses the cancer stem cell-like traits of nonsmall cell lung cancer cells by mediating RhoC ubiquitination
发表年份：2021 来源杂志：ENVIRONMENTAL TOXICOLOGY

123. Long non‑coding RNA LINC01224 promotes cell proliferation and inhibits apoptosis by regulating AKT3 expression via targeting miR‑485‑5p in endometrial carcinoma
发表年份：2021 来源杂志：ONCOLOGY REPORTS

124. Activation of Gonadotropin-releasing Hormone Receptor Impedes the Immunosuppressive Activity of Decidual Regulatory T Cells via Deactivating the Mechanistic Target of Rapamycin Signaling
发表年份：2021 来源杂志：IMMUNOLOGICAL INVESTIGATIONS

125. A novel circular RNA circ_HN1/miR-628-5p/Ecto-5’-nucleotidase competing endogenous RNA network regulates gastric cancer development
发表年份：2021 来源杂志：Bioengineered

126. Propofol modulates the proliferation, invasion and migration of bladder cancer cells through the miR‑145‑5p/TOP2A axis
发表年份：2021 来源杂志：Molecular Medicine Reports

127. Upregulated osteoprotegerin expression promotes lung cancer cell invasion by increasing miR‑20a expression
发表年份：2021 来源杂志：Experimental and Therapeutic Medicine

128. Fluorinated-functionalized hyaluronic acid nanoparticles for enhanced photodynamic therapy of ocular choroidal melanoma by ameliorating hypoxia
发表年份：2020 来源杂志：CARBOHYDRATE POLYMERS

129. The p53-inducible CLDN7 regulates colorectal tumorigenesis and has prognostic significance
发表年份：2020 来源杂志：NEOPLASIA

130. GKN2 promotes oxidative stress-induced gastric cancer cell apoptosis via the Hsc70 pathway
发表年份：2019 来源杂志：JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

131. Design, synthesis and biological evaluation of the thioether-containing lenalidomide analogs with anti-proliferative activities
发表年份：2019 来源杂志：EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

132. Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNA‑Meg3/miR‑421/PDGFRA axis
发表年份：2019 来源杂志：INTERNATIONAL JOURNAL OF ONCOLOGY

133. Elevated expression of AGGF1 predicts poor prognosis and promotes the metastasis of colorectal cancer
发表年份：2019 来源杂志：BMC CANCER

134. The miRNA-149-5p/MyD88 axis is responsible for ursolic acid-mediated attenuation of the stemness and chemoresistance of non-small cell lung cancer cells
发表年份：2019 来源杂志：ENVIRONMENTAL TOXICOLOGY

135. Glypican-3 promotes cell proliferation and tumorigenesis through up-regulation of β-catenin expression in lung squamous cell carcinoma
发表年份：2019 来源杂志：BIOSCIENCE REPORTS

136. miR-140-5p alleviates the aggressive progression of Wilms’ tumor through directly targeting TGFBR1 gene
发表年份：2019 来源杂志：Cancer Management and Research

137. Elevated MIR100HG promotes colorectal cancer metastasis and is associated with poor prognosis
发表年份：2019 来源杂志：Oncology Letters

138. miR-221/222 activate the Wnt/β-catenin signaling to promote triple-negative breast cancer
发表年份：2018 来源杂志：Journal of Molecular Cell Biology

139. The activation of microRNA-520h–associated TGF-β1/c-Myb/Smad7 axis promotes epithelial ovarian cancer progression
发表年份：2018 来源杂志：Cell Death & Disease

140. Covalent docking modelling-based discovery of tripeptidyl epoxyketone proteasome inhibitors composed of aliphatic-heterocycles
发表年份：2018 来源杂志：EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

141. Annonaceous acetogenin mimic AA005 suppresses human colon cancer cell growth in vivo through downregulation of Mcl-1
发表年份：2018 来源杂志：ACTA PHARMACOLOGICA SINICA

142. PYCR1 promotes the progression of non-small-cell lung cancer under the negative regulation of miR-488
发表年份：2018 来源杂志：BIOMEDICINE & PHARMACOTHERAPY

143. EZH2 Inhibition Ameliorates Transverse Aortic Constriction-Induced Pulmonary Arterial Hypertension in Mice
发表年份：2018 来源杂志：Canadian Respiratory Journal

144. Targeting endogenous DLK1 exerts antitumor effect on hepatocellular carcinoma through initiating cell differentiation
发表年份：2016 来源杂志：Oncotarget

145. Glyoxalase-1 Overexpression Reverses Defective Proangiogenic Function of Diabetic Adipose-Derived Stem Cells in Streptozotocin-Induced Diabetic Mice Model of Critical Limb Ischemia
发表年份：2016 来源杂志：Stem Cells Translational Medicine

146. Disruption and inactivation of the PP2A complex promotes the proliferation and angiogenesis of hemangioma endothelial cells through activating AKT and ERK
发表年份：2015 来源杂志：Oncotarget